RecruitingType 2 DiabetesAging
IH, Brain Health, and T2D
Eligible age
60–85 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).
Sponsor: Darren P Casey
You may qualify if…
- ✓ Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
- ✓ Age is \> or = 60 and \< or = 85 years of age
- ✓ Documented Type 2 diabetes
- ✓ Scoring 26 or higher on the MoCA test
- ✓ Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
- ✓ Age is \> or = 60 and \< or = 85 years of age
- ✓ Scoring 26 or higher on the MoCA test
You may not qualify if…
- ✕ diagnosis of type 2 diabetes \< 1 year prior to enrollment
- ✕ HbA1c \<6.5% or \>10.0%
- ✕ body mass index \> 40 kg/m 2
- ✕ incident cardiovascular events in the last year (heart attack, stroke)
- ✕ symptomatic coronary artery disease and/or heart failure
- ✕ uncontrolled hypertension
- ✕ obstructive sleep apnea
- ✕ pulmonary disease
Where it's recruiting
Iowa
Iowa City
Source: ClinicalTrials.gov · NCT07173543 · last updated 2026-03-13